Prestige Consumer Healthcare Inc. PBH
46.61
0.96
2.10%
as of 25 Sep
- Market cap
- $2.2B
- P/E
- 13.0×
Follow PBH
Growth Flags
show if company had growth for consecutive years
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
| 9.12% | 10.22% | 10.31% | 11.29% |
+8 more TTM periods Free account |
|
| 4.30% | 5.52% | 5.47% | 5.94% | ||
ROIC |
4.70% | 6.82% | 7.15% | 7.63% | |
Return on Tangible Assets |
37.38% | 44.03% | 44.19% | 46.07% | |
Average Days of Receivables |
61.89 | 64.34 | 62.99 | 65.41 | |
Free Cash Flow per Share |
4.96 | 5.09 | 5.58 | 5.21 | |
Free Cash Flow |
235.36 | 246.45 | 267.19 | 255.45 | |
Capital Expenditures |
(14.04) | (11.18) | (9.45) | (7.98) | |
Piotroski F-Score |
3.00 | 4.00 | 4.00 | 6.00 | |
| Other line items | |||||
Cash ROIC |
6.17% | 8.69% | 9.40% | 8.91% | |
Accounts Receivable Turnover |
6.21 | 5.64 | 6.17 | 6.13 | |
Accounts Payable Turnover |
17.39 | 23.64 | 15.51 | 13.34 | |
Inventory Turnover |
2.99 | 3.21 | 3.07 | 3.09 | |
Average Days of Payables |
26.20 | 16.87 | 32.37 | 31.39 | |
Days of Inventory on Hand |
135.22 | 117.79 | 123.29 | 119.04 | |
Tax Rate |
(0.27) | (0.26) | (0.30) | (0.30) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
25.32% | 24.36% | 23.91% | 23.26% | |
Share Based Compensation of Revenue |
1.01% | 1.00% | 0.99% | 0.99% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
1.45 | 1.35 | 1.48 | 1.31 | |
Depreciation/Fixed assets |
0.29 | 0.27 | 0.25 | 0.43 | |
Capex/Depreciation |
(0.41) | (0.34) | (0.30) | (0.26) | |
Revenue per Share |
23.28 | 22.47 | 23.05 | 22.65 | |
Operating CF per Share |
5.25 | 5.32 | 5.78 | 5.37 | |
Capex per Share |
(0.30) | (0.23) | (0.20) | (0.16) | |
Capex to Sales |
0.01 | 0.01 | 0.01 | 0.01 | |
Net Profit Margin |
15.57% | 17.48% | 16.90% | 18.09% |
Columns are period end dates